Silverback Therapeutics (SBTX) Stock Chart & Stock Price History → The new financial threat that could wipe out millions… (From InvestorPlace) (Ad) Free SBTX Stock Alerts $9.06 -0.41 (-4.33%) (As of 05/8/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsFinancialsInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsInsider TradesOwnershipSEC FilingsSocial Media Silverback Therapeutics Stock Price Performance5 Day Performance-7.08%1 Month Performance-8.76%3 Month Performance+43.81%6 Month Performance+152.37%Year-To-Date Performance+65.33%1 Year Performance+54.34% Receive SBTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Silverback Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsFidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>> SBTX Stock Chart for Wednesday, May, 8, 2024 SBTX Chart by TradingView Silverback Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$9.47$9.06-4.33%$9.55$8.98352,386 shs$326.69 million05/07/2024$9.45$9.47+0.21%$9.51$9.14474,003 shs$341.47 million05/06/2024$9.75$9.45-3.08%$9.80$9.10401,245 shs$340.75 million05/03/2024$9.46$9.75+3.07%$9.76$9.39364,083 shs$351.57 million05/02/2024$9.33$9.46+1.39%$9.51$8.94575,500 shs$341.11 million05/01/2024$8.70$9.33+7.24%$9.62$8.671.11 million shs$336.42 million Get the Latest News and Ratings for SBTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Silverback Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$8.60$8.70+1.16%$8.79$8.51335,331 shs$313.71 million04/29/2024$8.35$8.60+2.99%$8.72$8.41364,643 shs$310.10 million04/26/2024$8.09$8.35+3.21%$8.66$8.10520,296 shs$301.08 million04/25/2024$8.26$8.09-2.06%$8.19$7.66534,599 shs$291.71 million04/24/2024$8.21$8.26+0.61%$8.55$8.16334,673 shs$297.84 million04/23/2024$8.21$8.21$8.60$8.15394,656 shs$296.04 million04/22/2024$8.47$8.21-3.07%$8.60$8.15394,533 shs$296.04 million04/19/2024$9.06$8.44-6.84%$9.19$8.38918,109 shs$304.33 million04/18/2024$9.06$9.06$9.28$8.88456,563 shs$326.69 million04/17/2024$9.18$9.06-1.31%$9.28$8.88456,562 shs$326.69 million04/16/2024$9.24$9.18-0.65%$9.47$9.05477,151 shs$331.01 million04/15/2024$9.02$9.24+2.44%$9.30$8.95459,613 shs$333.18 million04/12/2024$9.27$9.02-2.70%$9.24$8.93689,994 shs$325.24 million04/11/2024$9.33$9.27-0.64%$9.42$9.03390,698 shs$334.26 million04/10/2024$9.33$9.33$9.99$9.13801,097 shs$336.42 million04/09/2024$9.93$9.33-6.04%$9.99$9.13801,097 shs$336.42 million04/08/2024$9.87$9.93+0.61%$10.10$9.65476,496 shs$358.06 million04/05/2024$9.53$9.87+3.57%$10.00$9.43442,942 shs$355.89 million04/04/2024$9.40$9.53+1.38%$9.70$9.35633,572 shs$343.63 million04/03/2024$9.28$9.40+1.29%$9.69$9.21551,467 shs$338.95 million04/02/2024$9.47$9.28-2.01%$9.62$9.27510,457 shs$334.62 million04/01/2024$10.22$9.47-7.34%$10.22$9.41722,938 shs$341.47 million03/29/2024$10.22$10.22$11.27$10.161.65 million shs$368.51 million03/28/2024$9.96$10.22+2.61%$11.27$10.161.64 million shs$368.51 million03/27/2024$10.00$9.96-0.40%$10.20$9.651.18 million shs$359.14 million03/26/2024$9.13$10.00+9.53%$10.15$9.182.38 million shs$360.58 million03/25/2024$8.65$9.13+5.55%$9.39$8.661.29 million shs$329.21 million03/22/2024$9.00$8.65-3.89%$9.10$8.56769,084 shs$311.90 million03/21/2024$8.70$9.00+3.45%$9.00$8.70731,298 shs$324.52 million03/20/2024$8.46$8.70+2.84%$8.85$8.41626,971 shs$313.71 million03/19/2024$9.12$8.46-7.24%$9.08$8.401.15 million shs$305.05 million03/18/2024$9.16$9.12-0.44%$9.39$8.951.16 million shs$328.85 million03/15/2024$9.00$9.16+1.78%$9.30$8.942.39 million shs$330.29 million03/14/2024$8.46$9.00+6.38%$9.00$8.78577,472 shs$324.52 millionThe new financial threat that could wipe out millions… (Ad)During the Internet boom, companies like Pets.com were supposed to be promising investments riding the wave of a new tech boom. But then they were gone within a blink of an eye. One of the most successful investors in history just stepped forward to say the same thing is about to happen to AI stocks.Pay close attention to this important video03/13/2024$8.46$8.46$8.49$8.25387,996 shs$305.05 million03/12/2024$8.29$8.46+2.05%$8.49$8.25387,996 shs$305.05 million03/11/2024$8.69$8.29-4.60%$8.78$8.25470,338 shs$298.92 million03/08/2024$8.95$8.69-2.91%$9.10$8.63521,458 shs$313.34 million03/07/2024$8.92$8.95+0.34%$9.06$8.61606,425 shs$322.72 million03/06/2024$8.65$8.92+3.12%$9.04$8.69549,558 shs$321.64 million03/05/2024$8.71$8.65-0.69%$8.75$8.46332,560 shs$311.90 million03/04/2024$8.71$8.71$8.87$8.42658,585 shs$314.07 million03/01/2024$9.02$8.37-7.21%$9.10$8.12972,060 shs$301.81 million02/29/2024$8.82$9.02+2.27%$9.19$8.831.17 million shs$325.24 million02/28/2024$8.75$8.82+0.80%$8.96$8.461.96 million shs$318.03 million02/27/2024$8.35$8.75+4.79%$9.15$8.201.40 million shs$315.51 million02/26/2024$8.35$8.35$8.50$7.66992,578 shs$301.08 million02/23/2024$7.60$7.60$7.79$7.50504,939 shs$274.04 million02/22/2024$7.52$7.60+1.06%$7.79$7.50504,510 shs$274.04 million02/21/2024$7.52$7.52$7.89$6.701.28 million shs$271.16 million02/20/2024$7.17$7.52+4.88%$7.89$6.701.28 million shs$271.16 million02/19/2024$7.17$7.17$7.25$7.09248,677 shs$258.54 million02/16/2024$7.10$7.17+0.99%$7.25$7.09248,177 shs$258.54 million02/15/2024$7.01$7.10+1.28%$7.33$7.02302,477 shs$256.01 million02/14/2024$7.46$7.01-6.03%$7.25$6.96494,074 shs$252.77 million02/13/2024$7.08$7.46+5.37%$7.87$7.16731,481 shs$268.99 million02/12/2024$7.08$7.08$7.11$6.49406,253 shs$255.29 million02/09/2024$6.30$6.49+3.02%$6.54$6.33268,353 shs$234.02 million02/08/2024$6.50$6.30-3.08%$6.59$6.29319,195 shs$227.17 million02/07/2024$6.37$6.50+2.04%$6.54$6.38331,182 shs$234.38 million Related Companies: NLTX Stock Price Chart AVIR Stock Price Chart ORGO Stock Price Chart FBLG Stock Price Chart RANI Stock Price Chart ERAS Stock Price Chart URGN Stock Price Chart TERN Stock Price Chart KMDA Stock Price Chart PGEN Stock Price Chart Receive SBTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Silverback Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SBTX) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarningsWatch this FREE trading tutorial while it’s still availableInvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silverback Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.